AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
Healthcare
$5.82 +2.48%
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
52W Low $8.75High $17.45
Volume 0.13M
Average 0.14M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2024 · Annual
Operating Income
-$48.02M
FY 2024 · Annual
Net Income
-$46.27M
FY 2024 · Annual
Income Statement
EUR
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin | — | — | — |
| Research & Development | 19.42M | 26.31M | 39.31M |
| Selling, General & Admin | 4.49M | 6M | 9.82M |
| Operating Expenses | 22.63M | 31.19M | 48.02M |
| Depreciation & Amortization | 23K | 99K | 311K |
| EBITDA | (10.74M) | (11.88M) | (45.89M) |
| EBITDA Margin | — | — | — |
| Operating Income | (22.63M) | (31.19M) | (48.02M) |
| Operating Margin | — | — | — |
| Interest Income | 71K | 245K | 1.22M |
| Interest Expense | 45K | 31K | 67K |
| Other Income / Expenses | 11.83M | 19.18M | 1.76M |
| Income Before Tax | (10.81M) | (12.01M) | (46.26M) |
| Pre-Tax Margin | — | — | — |
| Income Tax Expense | (2.66M) | (619K) | 4K |
| Net Income | (8.14M) | (11.39M) | (46.27M) |
| Net Margin | — | — | — |
| EPS (Basic) | (0.22) | (0.31) | (1.26) |
| EPS (Diluted) | (0.22) | (0.31) | (1.26) |
| 36.24M | 36.24M | 36.24M | |
| 36.24M | 36.24M | 36.24M |
AGMB Earnings Waterfall · TTM
NASDAQ:AGMB · Revenue to Net Income
No earnings data available.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 22, 2026 | |
| 6-K | 6-K filing | Oct 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 7, 2026 |
How much revenue does AGMB generate?
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) reported $0.00 of revenue in fiscal 2024.
Is AGMB profitable?
AgomAb Therapeutics N.V. American Depositary Shares (AGMB) reported -$46.27M of net income.
Continue the stock analysis
Jump to another research area for this company.